Kura Oncology
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $15,288 | $14,108 | $53,883 | $0 |
Gross Profit | 15,064 | 14,108 | 53,679 | -208 |
EBITDA | -72,666 | -64,700 | -16,592 | -53,784 |
EBIT | -72,890 | -57,585 | -16,796 | -53,992 |
Net Income | -66,122 | -57,429 | -19,217 | -54,404 |
Net Change In Cash | 15,288 | 14,108 | 53,883 | 0 |
Free Cash Flow | -30,235 | -72,219 | 268,759 | -43,440 |
Cash | 81,948 | 51,269 | 224,462 | 49,480 |
Basic Shares | 87,586 | 87,415 | 87,136 | 86,950 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $53,883 | $0 | $0 | $0 |
Gross Profit | 53,035 | -849 | -759 | -558 |
EBITDA | -169,498 | -164,955 | -134,852 | -129,706 |
EBIT | -170,346 | -165,804 | -135,611 | -130,264 |
Net Income | -173,983 | -152,631 | -136,069 | -129,908 |
Net Change In Cash | 53,883 | 0 | 0 | 0 |
Cost of Revenue | -38,870 | -234,821 | ||
Free Cash Flow | 133,845 | -124,992 | -110,688 | -105,698 |
Cash | 224,462 | 37,318 | 51,802 | 90,672 |
Basic Shares | 86,161 | 73,229 | 66,989 | 66,352 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.75 |
2025-03-31 | -$0.66 |
2024-12-31 | -$0.22 |
